UTFacultiesEEMCSDisciplines & departmentsBIOSStudent AssignmentsIntegrated CRISPR/Cas Microfluidics for Point-of-Care ctDNA Detection

Integrated CRISPR/Cas Microfluidics for Point-of-Care ctDNA Detection

Early detection of cancer can be useful in improving patient outcomes. Circulating tumor DNA (ctDNA) is a minimally invasive, highly informative biomarker for measuring cancer progression and treatment responses. Current liquid-biopsy methods, however, require lengthy processing timelines, which make real-time decision making in clinical settings a challenge and cancer management less efficient.

CRISPR/Cas based nucleic acid detection is a powerful, highly specific technique that can be used for real-time detection. When integrated on a microfluidic platform, detection and quantification of cancer biomarkers can be done rapidly and with minimal input volumes, enabling a point-of-care technology for real-time cancer management.

The aim of this project is to design, fabricate and validate a microfluidic chip that integrates a CRISPR/Cas assay for real-time detection of target ctDNA, using a laser-based fluorescence readout system. You will carry out the lab-based biochemical assay of CRISPR/Cas sensing on the chip you designed and record the fluorescence readout with a newly developed laser-based setup. At the same time, you will validate your assay on a standard plate reader in the DNA lab.


Contact information

If you have questions or are interested in doing a master assignment in this project, feel free to contact us: